The global Therapeutic Plasma Exchange (TPE) Systems market is entering a high-growth phase as healthcare systems worldwide accelerate the adoption of advanced apheresis technologies. Valued at USD 447 million in 2024, the market is projected to reach USD 675 million by 2031, expanding at a CAGR of 6.6%. This growth is driven by rising cases of autoimmune neurological disorders, hematological...